Passage Bio share price logo

Passage Bio

NASDAQ: PASG

$3.50

-0.10

(-2.78%)

as on

Passage Bio Stock Performance

as on October 17, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $3.38
    $3.76
    downward going graph

    3.43%

    Downside

    7.43%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.29
    $20.00
    downward going graph

    6.00%

    Downside

    471.43%

    Upside

    downward going graph

Passage Bio share price movements today

Previous Close
$3.60
Open
$3.61
Volume
204.4K
Market Cap
$11.6M
Day's Low - High
$3.38 - $3.76
52 Week Low - High
$3.29 - $20.00

Passage Bio Historical Returns

1 Month Return
-30.56 %
3 Month Return
-27.54 %
1 Year Return
-56.63 %
3 Year Return
-74.26 %
5 Year Return
-98.21 %

Passage Bio Stock Fundamentals & Key Indicators

Check Passage Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.6M

EPS (TTM)

-11.33

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.32

Industry PE ratio

-3.02

PEG Ratio

-0.01

EBITDA

-33.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-218.59%

Passage Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Passage Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$11.6M-98.21%-0.320.00%0.00%
Neutral$94.4B-32.76%-29.64-12.57%0.00%
StrongBuy$128.9B174.93%29.3786.04%0.00%
Buy$80.1B42.93%19.0184.86%0.46%

Stock Returns calculator for Passage Bio Stock including INR - Dollar returns

The Passage Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Passage Bio investment value today

Current value as on today

₹46,867

Returns

-₹53,133

(-53.13%)

Returns from Passage Bio Stock

-₹56,629 (-56.63%)

Dollar Impact

₹3,497 (+3.5%)

Analyst Recommendation on Passage Bio Stock

Based on 1 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'HOLD' rating for Passage Bio. Average target price of $15.5

Passage Bio Share Price Target

Get share price movements and forecasts by analysts on Passage Bio.

What analysts predicted

77.42%UPSIDE

Target Price

$15.5

Current Price

$3.5

Analyzed by

1 Analysts

Target

$15.50

Passage Bio target price $15.5, a slight upside of 77.42% compared to current price of $3.5. According to 1 analysts rating.

Indian Investors' Interest in Passage Bio Stock

Search interest for Passage Bio Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Passage Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
-
0
-
-
0
-
Operating Income
-18
-17
-20
-14
-16
-10
-8
-13
-8
-8
EBITDA
-15
-16
-15
-12
-13
-9
-7
-10
-7
-7
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-15
-19
-12
-15
-9
-7
-12
-7
-7
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-16
-15
-19
-12
-15
-9
-7
-12
-7
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Passage Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-3
-
0
Operating Income
-13
-37
-112
-185
-138
-100
-70
-43
EBITDA
-7
-36
-111
-176
-131
-98
-62
-44
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
-
0
0
1
3
3
3
0
Income Before Tax
-12
-45
-112
-185
-136
-102
-64
-45
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-12
-45
-112
-185
-136
-102
-64
-45
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Passage Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
-15
-19
-12
-15
-9
-7
-12
-7
-7
Operating Cash Flow
-18
-13
-7
-8
-13
-6
-4
-6
-12
-9
Investing Cash Flow
25
1
14
13
39
0
-
-
0
-
Financing Cash Flow
8
0
-
0
-
0
-
0
-
-
Change in Cash
15
-12
7
5
25
-5
-4
-6
-12
-9

Passage Bio Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-45
-112
-185
-136
-102
-64
-45
Operating Cash Flow
-18
-39
-80
-126
-118
-78
-47
-31
Investing Cash Flow
-2
-1
-172
-45
25
65
54
40
Financing Cash Flow
45
175
228
166
-1
0
8
0
Change in Cash
24
134
-23
-6
-94
-12
15
8

Global Institutional Holdings in Passage Bio

Check out the Institutions with significant holdings in Passage Bio.

Funds
Holdings
VANGUARD INDEX FUNDS
3.54%
Vanguard
3.54%
Fidelity Commonwealth Trust II
1.20%
Fidelity Concord Street Trust
0.60%
Victory Portfolios III
0.10%

Insights on Passage Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 794.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 153.5% return, outperforming this stock by 226.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, PASG stock has moved down by -70.0%

About Passage Bio

Passage Bio, Inc. is a biopharmaceutical company dedicated to pioneering genetic therapies for conditions affecting the central nervous system. Their advanced pipeline includes PBGM01, designed to treat infantile GM1 gangliosidosis by utilizing a proprietary AAVhu68 capsid to deliver a functional GLB1 gene, which codes for the lysosomal acid beta-galactosidase enzyme, to both the brain and peripheral tissues. Another key program, PBFT02, employs an AAV1 capsid to introduce a functional granulin (GRN) gene, encoding progranulin (PGRN), to the brain as a treatment for FTD-GRN. Additionally, PBKR03 is under development for infantile Krabbe disease, leveraging a proprietary AAVhu68 capsid to deliver a functional GALC gene, responsible for producing the hydrolytic enzyme galactosylceramidase, to the brain and surrounding tissues. The company's portfolio also features PBML04 for metachromatic leukodystrophy, PBAL05 for amyotrophic lateral sclerosis, and PBCM06 for Charcot-Marie-Tooth Type 2A. Passage Bio maintains a significant research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program, alongside a development services and clinical supply agreement with Catalent Maryland, Inc. Established in 2017, the company's headquarters are located in Philadelphia, Pennsylvania.
OrganisationPassage Bio
HeadquartersOne Commerce Square, Philadelphia, PA, 19103, US
IndustryBiotechnology
CEOWilliam Chou

Key Management of Passage Bio

Name

Title

Ms. Kathleen Borthwick

Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer

Dr. William Chou M.D., Ph.D.

President, CEO & Director

FAQs

What is Passage Bio share price today?

Passage Bio share price today is $3.50 as on at the close of the market. Passage Bio share today touched a day high of $3.76 and a low of $3.38.

What is the 52 week high and 52 week low for Passage Bio share?

Passage Bio share touched a 52 week high of $20.00 on and a 52 week low of $3.29 on . Passage Bio stock price today i.e. is closed at $3.50,which is 82.50% down from its 52 week high and 6.38% up from its 52 week low.

What is Passage Bio's market capitalisation today?

Passage Bio market capitalisation is $0.00T as on .

How to invest in Passage Bio Stock (PASG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Passage Bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Passage Bio Stock (PASG) from India?

Indian investors can start investing in Passage Bio (PASG) shares with as little as ₹94.959999084473 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Passage Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Passage Bio share’s latest price of $3.50 as on October 17, 2026 at 8:45 am IST, you will get 2.8571 shares of Passage Bio. Learn more about fractional shares .

What are the returns that Passage Bio has given to Indian investors in the last 5 years?

Passage Bio stock has given -98.21% share price returns and 26.39% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?